# The Effect of Curcumin on Liver Fat Content in Obese Subjects

> **NCT03864783** · NA · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 39 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Insulin Resistance
- Glucose Tolerance Impaired
- Obesity, Abdominal

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin (Meriva®)
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03864783
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-05
- **Primary completion:** 2020-12-16
- **Final completion:** 2020-12-16
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2021-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03864783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03864783, "The Effect of Curcumin on Liver Fat Content in Obese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03864783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*